Smarter blood tests deliver faster diagnoses, improved outcomes

New research can identify more proteins, or biomarkers, in blood plasma, including those linked to specific diseases like cancer.

By identifying these biomarkers earlier, medical researchers can create better diagnostic tests and drugs that target diseases sooner.

The new method reduces interference from the most common proteins in blood, allowing researchers to detect lesser-known, low-abundance proteins that are often crucial in identifying diseases.